[HTML][HTML] The role of NMDA receptors in Alzheimer's disease

J Liu, L Chang, Y Song, H Li, Y Wu - Frontiers in neuroscience, 2019 - frontiersin.org
In Alzheimer's disease (AD), early synaptic dysfunction is associated with the increased
oligomeric amyloid-beta peptide, which causes NMDAR-dependent synaptic depression …

[HTML][HTML] Extrasynaptic NMDA receptors in acute and chronic excitotoxicity: implications for preventive treatments of ischemic stroke and late-onset Alzheimer's disease

SP Yu, MQ Jiang, SS Shim, S Pourkhodadad… - Molecular …, 2023 - Springer
Stroke and late-onset Alzheimer's disease (AD) are risk factors for each other; the
comorbidity of these brain disorders in aging individuals represents a significant challenge …

[HTML][HTML] The neuroprotective effects of exercise: maintaining a healthy brain throughout aging

LM Vecchio, Y Meng, K Xhima, N Lipsman… - Brain …, 2018 - content.iospress.com
Physical activity plays an essential role in maintaining a healthy body, yet it also provides
unique benefits for the vascular and cellular systems that sustain a healthy brain. While the …

Synaptic plasticity in Alzheimer's disease and healthy aging

DM Cuestas Torres, FP Cardenas - Reviews in the Neurosciences, 2020 - degruyter.com
The strength and efficiency of synaptic connections are affected by the environment or the
experience of the individual. This property, called synaptic plasticity, is directly related to …

Glutamatergic synaptic plasticity and dysfunction in Alzheimer disease: Emerging mechanisms

EE Benarroch - Neurology, 2018 - AAN Enterprises
Impaired synaptic plasticity and dendritic loss in excitatory glutamatergic synapses are early
events in Alzheimer disease (AD). These synaptic abnormalities are triggered by …

Building a bridge between NMDAR-mediated excitotoxicity and mitochondrial dysfunction in chronic and acute diseases

RG Mira, W Cerpa - Cellular and Molecular Neurobiology, 2021 - Springer
Glutamate is the major excitatory neurotransmitter in the brain, and it is widely accepted to
play a role in synaptic plasticity and excitotoxic cell death. Glutamate binds to several …

[HTML][HTML] CIP2A causes Tau/APP phosphorylation, synaptopathy, and memory deficits in Alzheimer's disease

YP Shentu, Y Huo, XL Feng, J Gilbert, Q Zhang… - Cell reports, 2018 - cell.com
Summary Protein phosphatase 2A (PP2A) inhibition causes hyperphosphorylation of tau
and APP in Alzheimer's disease (AD). However, the mechanisms underlying the …

[HTML][HTML] Obesity as a risk factor for Alzheimer's disease: implication of leptin and glutamate

A Lloret, P Monllor, D Esteve, A Cervera-Ferri… - Frontiers in …, 2019 - frontiersin.org
Obesity is known to induce leptin and insulin resistance. Leptin is a peptide hormone
synthesized in adipose tissue that mainly regulates food intake. It has been shown that …

The role of N-methyl-D-aspartate glutamate receptors in Alzheimer's disease: From pathophysiology to therapeutic approaches

W Liu, Y Li, T Zhao, M Gong, X Wang, Y Zhang… - Progress in …, 2023 - Elsevier
N-Methyl-D-aspartate glutamate receptors (NMDARs) are involved in multiple
physiopathological processes, including synaptic plasticity, neuronal network activities …

[HTML][HTML] Codonopsis pilosula polysaccharide attenuates Aβ toxicity and cognitive defects in APP/PS1 mice

L Wan, Q Zhang, H Luo, Z Xu, S Huang, F Yang… - Aging (Albany …, 2020 - ncbi.nlm.nih.gov
Abstract Codonopsis pilosula Polysaccharides (CPPs), a traditional Chinese medicine used
for thousands of years, is a potential neuroprotective polysaccharide via a relatively poorly …